Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA Warns Syntec Pharma Against Sourcing APIs From Import-Alerted Suppliers

Executive Summary

Import alerts, warning letters failed to deter company from importing adulterated drug substances. Syntec also cited for cross-contamination, cleaning lapses.

You may also be interested in...



BARDA Expands US Domestic Production Of Single-Use Systems For Vaccine Manufacturing

FlexBiosys wins award; others to follow. New capacity may also benefit manufacture of monoclonal antibodies and cell and gene therapies.

Communication Is Key In Adapting Production To Pandemic Component Supply Disruptions

US FDA is looking at risk-based approach for reporting changes in out-of-stock components such as plastic bioreactor bags, filters and tubing sets that are in short supply.

US FDA Must Assess Business Impact Of Final Interstate Compounding MOU, Court Rules

Summary judgment puts 20-year-old effort to define ‘inordinate’ out-of-state drug compounding back on slow track.

UsernamePublicRestriction

Register

PS144745

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel